Sponsored Links
Diabetes Mellitus type-2 has been an epidemic in developing countries in Asia, such as Indonesia, and in developed country like United States of America. Cardiovascular diseases have a very high morbidity & mortality rate in a population of patients with DM type-2. Maintaining a normal blood glucose, particularly early in the disease, can slow down or even prevent complication, keeps β cells functioning well, presses down DM type-2 early morbidity and mortality rate.
Recently there is a new option of medication, that are capable of achieving the target to press down blood glucose and better results generally. Two major characteristic of DM type-2 - insulin resistancy defect and insulin deficiency, are the main target of this new medication. The major advantage of this new medication is to achieve the target of controlling blood glucose by improving sensitivity to insulin, repairing cells disfunction, decreasing cardiovascular complications, then pressing down DM type-2 morbidity and mortality.
0 comments:
Post a Comment